BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND TPM3, ENSG00000143549, 7170
68 results:

  • 1. Molecular Screening in Anaplastic lymphoma Kinase-Positive Anaplastic Large Cell lymphoma: Anaplastic lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
    Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
    Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients.
    Zhou X; Weng Y; Jiang T; Ou W; Zhang N; Dong Q; Tang X
    BMC Cancer; 2023 Oct; 23(1):976. PubMed ID: 37833648
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A cutaneous epithelioid vascular tumor harboring a tpm3::ALK fusion.
    Linos K; Chang JC; Busam KJ
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23207. PubMed ID: 37787425
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report.
    Kai K; Tobu S; Kido S; Mikami S; Takeuchi K; Dobashi A; Togashi Y; Noguchi M; Aishima S
    Diagn Pathol; 2022 Jun; 17(1):52. PubMed ID: 35718773
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy.
    Baranov E; Winsnes K; O'Brien M; Voss SD; Church AJ; Janeway KA; DuBois SG; Davis JL; Al-Ibraheemi A
    Histopathology; 2022 Aug; 81(2):215-227. PubMed ID: 35543076
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Spitz nevus with EHBP1-ALK fusion and distinctive membranous localization of ALK.
    Bahrani E; Kunder CA; Teng JM; Brown RA; Rieger KE; Novoa RA; Cloutier JM
    J Cutan Pathol; 2022 Jun; 49(6):584-588. PubMed ID: 35113459
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
    Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
    Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC.
    Li W; Guo L; Liu Y; Dong L; Yang L; Chen L; Liu K; Shao Y; Ying J
    J Thorac Oncol; 2021 Mar; 16(3):404-418. PubMed ID: 33248323
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Minimal Residual Disease Monitoring Using a 3'ALK Universal Probe Assay in ALK-Positive Anaplastic Large-Cell lymphoma: ddPCR, an Attractive Alternative Method to Real-Time Quantitative PCR.
    Quelen C; Grand D; Sarot E; Brugières L; Sibon D; Pradines A; Laurent C; Brousset P; Lamant L
    J Mol Diagn; 2021 Feb; 23(2):131-139. PubMed ID: 33246076
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation.
    Zhao S; Liu W; Li S; Shi T; Chen Q; Li Q; Sun L; Ren D; Song Z; Huang C; Xu S
    Cancer Res Treat; 2021 Apr; 53(2):601-606. PubMed ID: 33091968
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.
    Leal JL; Peters G; Szaumkessel M; Leong T; Asadi K; Rivalland G; Do H; Senko C; Mitchell PL; Quing CZ; Dobrovic A; Thapa B; John T
    Lung Cancer; 2020 Aug; 146():154-159. PubMed ID: 32540558
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.
    Kuroda N; Trpkov K; Gao Y; Tretiakova M; Liu YJ; Ulamec M; Takeuchi K; Agaimy A; Przybycin C; Magi-Galluzzi C; Fushimi S; Kojima F; Sibony M; Hang JF; Pan CC; Yilmaz A; Siadat F; Sugawara E; Just PA; Ptakova N; Hes O
    Mod Pathol; 2020 Dec; 33(12):2564-2579. PubMed ID: 32467651
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical, Histologic, and Molecular Characteristics of Anaplastic lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell lymphoma.
    Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
    Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Characteristics of Renal Cell Carcinoma Harboring
    Woo CG; Yun SJ; Son SM; Lim YH; Lee OJ
    Yonsei Med J; 2020 Mar; 61(3):262-266. PubMed ID: 32102128
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology.
    Hang JF; Chung HJ; Pan CC
    Virchows Arch; 2020 Jun; 476(6):921-929. PubMed ID: 31993771
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ALK-tpm3 rearrangement in adult renal cell carcinoma: a case report and literature review.
    Yang J; Dong L; Du H; Li XB; Liang YX; Liu GR
    Diagn Pathol; 2019 Oct; 14(1):112. PubMed ID: 31627758
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Different Types of
    He Y; Sheng W; Hu W; Lin J; Liu J; Yu B; Mao X; Zhang L; Huang J; Wang G
    Oncol Res; 2019 Aug; 27(8):901-910. PubMed ID: 30940295
    [No Abstract]    [Full Text] [Related]  

  • 18. Fusion of ALK to the melanophilin gene MLPH in pediatric Spitz nevi.
    Chung CT; Marrano P; Swanson D; Dickson BC; Thorner PS
    Hum Pathol; 2019 May; 87():57-64. PubMed ID: 30857967
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects.
    Kuroda N; Sugawara E; Kusano H; Yuba Y; Yorita K; Takeuchi K
    Pol J Pathol; 2018; 69(2):109-113. PubMed ID: 30351856
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study.
    Vaughn CP; Costa JL; Feilotter HE; Petraroli R; Bagai V; Rachiglio AM; Marino FZ; Tops B; Kurth HM; Sakai K; Mafficini A; Bastien RRL; Reiman A; Le Corre D; Boag A; Crocker S; Bihl M; Hirschmann A; Scarpa A; Machado JC; Blons H; Sheils O; Bramlett K; Ligtenberg MJL; Cree IA; Normanno N; Nishio K; Laurent-Puig P
    BMC Cancer; 2018 Aug; 18(1):828. PubMed ID: 30115026
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.